Litcius/Paper detail

[Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor

Xiaoli Pang, Kexin Huang, Qianqian Zhang, Yujiao Zhang, Junqi Niu

2021Oncology Reports37 citationsDOIOpen Access PDF

Abstract

Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that certain of the western blotting data shown in Fig. 3C, 4D, 5A and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to <em>Oncology Reports</em>, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in <em>Oncology Reports</em> 34: 3272‑3279, 2015; DOI: 10.3892/or.2015.4321]

Topics & Concepts

OncogeneAudience measurementEditorial boardMedicineCancer researchClinical OncologyOncologyCancerLibrary scienceCell cyclePolitical scienceInternal medicineComputer scienceLawRNA modifications and cancerMicroRNA in disease regulationCancer-related molecular mechanisms research
[Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor | Litcius